Re: An FGFR3/MYC Positive Feedback Loop Provides New Opportunities for Targeted Therapies in Bladder Cancers

J Urol. 2018 Nov;200(5):947-948. doi: 10.1016/j.juro.2018.07.074. Epub 2018 Aug 7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Receptor, Fibroblast Growth Factor, Type 3
  • Urinary Bladder Neoplasms*

Substances

  • FGFR3 protein, human
  • Receptor, Fibroblast Growth Factor, Type 3